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Introduction
Malaria infection during pregnancy is a serious public health issue in sub-Saharan Africa with approximately 30 million pregnant women being at risk of pregnancy-associated-malaria (Dellicour et al., 2010) . The symptoms and complications of malaria infection during pregnancy may vary according to the level of malaria transmission in different geographical areas and the level of acquired immunity (Okell et al., 2009) . In high-transmission areas, most infections during pregnancy are asymptomatic but still result in poor pregnancy outcome (Steketee et al., 1996; Mockenhaupt et al., 2000; Nosten et al., 2004) . A high proportion of individuals living in malaria-endemic areas harbour P. falciparum parasites undetectable by microscopy -therefore called sub-microscopic infection -which can nevertheless be identified using molecular tools like PCR (Snounou et al., 1993) . Sub-microscopic infection is common during pregnancy and at delivery (Cottrell et al., 2015) . To reduce the burden of malaria infections in pregnant women, the World Health Organization (WHO) has recommended a package of interventions, including the use of long-lasting insecticidal nets (LLINs) and administration of sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment of malaria during pregnancy (IPTp) (WHO, 2005) . In the Republic of Congo, a malaria-endemic country in Central Africa with perennial transmission (Trape and Zoulani, 1987) , the administration of IPTp-SP (2 or 3 doses) during pregnancy has been in place since 2006. The study conducted in asymptomatic pregnant women in Brazzaville revealed a reduction of the prevalence of P. falciparum infection (Ntoumi et al., 2016) . However, high resistance to SP has been found in parasites collected from Congolese pregnant women (Koukouikila-Koussounda et al., 2015) . The development of an effective vaccine is the one of the major challenges of the fight against malaria. However, this approach is limited by the polymorphic nature of Plasmodium (Mayengue et al., 2004; Ntoumi et al., 2016; Guitard et al., 2010; Cohee et al., 2016) . The susceptibility of pregnant women to malaria is explained by the presence of parasite strains that specifically bind to the chondroitin sulphate A (CSA) present in the placental tissue (Fried and Duffy, 1996; Duffy and Fried, 1999) . Investigating of genotype and the circulating parasites in pregnant women is interesting for the malaria vaccine (Genton et al., 2002; Takala et al., 2007; Takala and Plowe, 2009) . Several previous studies on the antigenic diversity of P. falciparum matched in peripheral, placental and umbilical cord blood have shown varied results in different country. Some studies have shown a parasitic overlap found for each of these compartments while others have revealed a subpopulation of peripheral parasites sequestered in the placenta (Kassberger et al., 2002; Mayengue et al., 2004; Fadlelseed et al., 2017; Guitard et al., 2010; Cohee et al., 2016) . Recent published work conducted in the same area reported 29 MSP-2 alleles in isolates from peripheral blood of pregnant women with asymptomatic P. falciparum infection at antenatal visits, suggesting a wide diversity of the P. falciparum population (Ntoumi et al., 2016) . Therefore, the present cross-sectional study was conducted to characterize P. falciparum infections matched in peripheral, placental and cord blood among Congolese women at delivery receiving 1, 2 or more doses of sulfadoxine-pyrimethamine.
Materials and methods

Study site
The study was carried out at Madibou Integrated Health Center, located in the semi-urban area of Makélékélé district, Southern part of Brazzaville, the capital of the Republic of Congo. This area with about 6.000 inhabitants is situated along the Congo River, where malaria transmission is intense and continuous throughout the year. The entomological inoculation rate is approximately 23 infective bites/ person/year (Trape and Zoulani, 1987) . P. falciparum is the predominant malaria species and Anopheles gambiae s.s the main mosquito vector.
Study population
Between March 2014 and April 2015, a total of 370 pregnant women were recruited at the maternity ward. The inclusion criteria were as follows: signed informed consent obtained from the participant at admission before delivery, no episodes of clinical malaria during the last two weeks, no notion of fever at least 48 h before enrolment and an axillary temperature ≤ 37.5°C during the examination. Socio-demographic data were recorded using a structural questionnaire and from medical records.
Ethics
The study was approved by the Institutional Ethics Committee of the Fondation Congolaise pour la Recherche Médicale (ethical clearance No 001/CEI/FCRM/2012). Written informed consent was obtained from all pregnant women before enrolment.
Blood collection and treatment of samples
A total volume of 5 ml of peripheral blood was collected before delivery, 5 ml placental intervillous and umbilical cord blood were collected within 30 min after delivery into EDTA tubes for the detection of and quantification of malaria parasites. Thick blood smears were prepared for each blood compartment, stained with 10% Giemsa solution for 15 min, and examined by an experienced microscopist. Trophozoites were counted concomitantly with 200 leukocytes, and expressed in number of asexual parasites per μL of blood, assuming the leukocyte count of 8.000/μL of blood. The rest of the blood was spun to separate cells from plasma and stored separately at −20°C for future use.
2.5. DNA extraction and characterization of P. falciparum isolates Genomic DNA was extracted separately from peripheral, placental and cord blood using the QIAmp DNA Blood Mini kit (QIAGEN GmbH, Hilden, Germany) according to manufacturer instructions. Parasite isolates were genotyped for P. falciparum using the nested PCR technique, targeting the highly polymorphic locus MSP-2 central region as previously described (Ntoumi et al., 2016) . The initial amplifications were followed by individual nested PCR reactions, using specific primers for FC27 and 3D7 allelic families of the MSP-2 gene. Allele-specific positive controls (3D7 and Dd2) and DNA-free water as a negative control were included in each set of reactions. Each PCR product was stained with Sybr Green, loaded on a 2% agarose gel, and visualized under ultraviolet trans-illumination. Various alleles were determined by their amplicon sizes and the corresponding allele-specific primers used. The sizes of PCR product were estimated using a 100 bp DNA ladder marker (Invitrogen, Karlsruhe, Germany). It was assumed that one band represented one amplified PCR fragment derived from a single copy of P. falciparum MSP-2 gene. Alleles in each family were considered as one if fragment sizes were within a 20 bp interval. The number of different MSP-2 fragments identified per isolate was considered as the minimum number of parasite genotypes present in this isolate. The amplified PCR products from the different blood compartments for the one woman were run in the same gel to ensure a better comparison.
Case definitions
Asymptomatic P. falciparum infection was defined as the presence of malaria parasites in blood in the absence of any clinical symptom. Peripheral, placental and cord blood isolates were grouped into a) P. falciparum microscopy positive infection; b) P. falciparum infection that were negative by microscopy but detected by PCR (sub-microscopic infection); c) negative individuals who were negative by both microscopy and PCR. The genetic diversity of MSP-2 alleles was determined as the total number of different MSP-2 fragments amplified. The multiplicity of infection (MOI) was defined as the mean number of P. falciparum genotypes per infected woman. Gravidity was grouped as paucigravidae (First and second full-term pregnancies), and multigravidae (3rd full term pregnancies).
Statistical analysis
All statistical analyses were performed using R (version 3.5.1) under the RStudio environment (1.1.456). To evaluate the impact of different factors (age, gravidity, SP), we applied non-parametric tests, since the multiplicity of infections takes discrete values, and does thus not comply with the normality assumption required for parametric tests. For two-group comparisons (age, gravidity) we applied Wilcoxon test. For multi-group comparisons (number of SP doses) we ran a Kruskal-Wallis test. For multi-group comparisons between compartments (prevalence of infection; allelic diversity), we applied the Kruskal-Wallis test. The statistical significance threshold was set to P < 0.05.
Results
Characteristics of the study population
From March 2014 to April 2015, a total of 370 women were enrolled in the study. The characteristics of the women are shown in Table 1 .
Prevalence of P. falciparum asymptomatic infection
Overall, matched peripheral, placental and cord blood samples from all study participants were analysed. The prevalence of P. falciparum microscopic infection in peripheral blood was 7.3% and that of placental blood was 2.7% (Table 2) . Not a single sample was found microscopic positive in cord blood ( Table 2 ). The prevalence of P. falciparum sub-microscopic infections was 25.4% in peripheral blood, 16.7% in placental blood and 9.4% in cord blood (Table 2 ). All the microscopy-positive peripheral and placental blood samples were positive by PCR. The overall (microscopy-positive and sub-microscopic infections put together) prevalence of P. falciparum sub-microscopic infection was 30.8% in peripheral blood and 19.4% in placental blood ( Table 2) .
Out of 87 (25.4%) of women with peripheral sub-microscopic infections, 9 (4.6%) had placental infections and 11 (12.6%) had infections in cord. Out of 60 (16.7%) of women with placental sub-microscopic infections, 4 (6.7%) samples were matched in cord. Furthermore, 62 (71.3%), 42 (70%) and 15 (42.8%) positive samples were detected exclusively in peripheral, placental and cord respectively. Overall, 5 cases of P. falciparum sub-microscopic infections matched in peripheral, placental and cord samples (Fig. 1). 
Distribution of P. falciparum MSP-2 alleles
With regard to the genetic diversity, the distribution of different MSP-2 alleles is shown in Table 3 . A total, 30, 25 and 19 (P = 0.29) alleles were detected respectively in the peripheral, placental and cord samples. The 3D7 family was predominant whatever sample types. The mixed 3D7 and FC27 alleles were more prevalent in peripheral samples (26.3%) ( Table 3) .
The 3D7 and FC27 alleles identified in the paired peripheral / placental, peripheral / cord and placental / cord blood samples were compared. The proportion of samples matched with identical and partially concordant alleles is shown in Fig. 2 , which summarizes the number of alleles found in peripheral, placental and cord blood. Some samples revealed the same alleles in the three compartments. In other cases, one or both samples had alleles not detected in the other ones.
Multiplicity of P. falciparum infections
The MOI was 1.4 ± 0.01 (ranged 1-4 clones) in peripheral, 1.2 ± 0.01 (range 1-3 clones) in placental and 1.4 ± 0.01 (ranged 1-3 clones) in cord samples. Of 114 infected samples from peripheral blood, 110 (96.5%) contained single and 40 (35.1%) multiples infections. Of the 70 infected samples from placental blood, 46 (65.7%) harboured single and 24 (34.3%) multiples infections. In cord, 32 (91.4%) of 35 infected samples contained multiples infections and 3 (8.6%) samples have single infection. The MOI was neither affected by maternal age, nor gravidity or SP doses administered (Table 4) .
Discussion
The current study is the first of its kind to evaluate the frequency of sub-microscopic P. falciparum infection among malaria asymptomatic Congolese women at delivery. The main findings of this study are the high prevalence of sub-microscopic infection at delivery, high diversity of parasites circulating in the population, and differential patterns of MSP-2 allelic families in matched peripheral, placental and umbilical cord parasite isolates from even the same individual.
The prevalence of sub-microscopic P. falciparum infection in the peripheral and placental blood was higher than microscopic infection in all compartments. In the cord compartment, the P. falciparum infection was found only by PCR. This indicates that the threshold of detection of P. falciparum by microscopy in pregnant women strongly under-estimates the actual infection rates (Ntoumi et al., 2016; Mockenhaupt et al., 2000) . Thus, reliance on microscopy may lead to miss diagnosis and failure to avert adverse effect of malaria during pregnancy (Mockenhaupt et al., 2000; Ntoumi et al., 2013; Ntoumi et al., 2016) .
The prevalence of sub-microscopic infection was generally high at delivery. This suggests that pregnant women remained at increased risk of new infections during the late period of their pregnancies after receiving IPTp-SP, which is mostly administered during the second trimester. This increased danger may explain why despite the risk of infection being significantly reduced among delivered women who received 2 or 3 doses of IPTp-SP, there were still about 20% who harboured sub-microscopic infection. The proportion of sub-microscopic infection in our study is quite small compared to those reported from Gabon (Tshibola Mbuyi et al., 2014) . This difference might be due to the transmission intensity of the parasite at the different study sites and possibly differential host factors such as a degree of immunity that might restrict parasites growth to microscopically undetectable levels. Alternatively, these low-density infections may represent recently acquired infections, which could reach detectable levels by microscopy if infections were not treated. All microscopic placental blood infections were microscopically detectable in the peripheral blood. However, 42 women with sub-microscopic infection of the placental blood showed no evidence of peripheral blood infection. During pregnancy, parasites expressing a ligand for chondroitin sulphate A tend to adhere to placenta and sequester in this unique compartment (Fried and Duffy, 1996) and are rarely detected in the peripheral blood. This might have accounted for the observation made in these 42 participants. The prevalence of placental P. falciparum infection was lower than peripheral, which is consistent with some of the previous reports (Omalu et al., 2012; Hviid, 2011) but not with others (Mayengue et al., 2004; Ouédraogo et al., 2012) . The high prevalence of infection in peripheral than placenta blood may explain the new P. falciparum infections in third trimester of pregnancy.
Asymptomatic P. falciparum infection is highly prevalent in malaria endemic regions, which raises a serious concern about the efforts at eliminating the parasite (Riley et al., 2001 ). Particularly, sub-patent malaria is still transmissible and will complicate the elimination of malaria in high-transmission regions (Sturrock et al., 2013) . Most studies suggested that exposed individuals are likely to carry chronic asymptomatic P. falciparum infections (Sturrock et al., 2013; Ouédraogo et al., 2016) , a situation in which the majority of this population can act Y. Mbouamboua, et al. Acta Tropica 193 (2019) 142-147 as a reservoir for malaria transmission. Our results showed 15 women with sub-microscopic infection in the cord samples with no evidence of infection in peripheral and/or placental samples. The unique presence of certain parasites in the cord can be explained by parasite clearance in the placenta and / or maternalfoetal transfusions before or during birth (Riley et al., 2001) .
The MSP-2 marker is very polymorphic. We detected 24 distinct 3D7 alleles and 20 distinct FC27 alleles. Similar results were observed in Gabon (Kassberger et al., 2002; Mayengue et al., 2004) in Senegal (Schleiermacher et al., 2001) . The 3D7/MSP2 allele was predominant such as reported in the previous report in the same site (Ntoumi et al., 2016) . Similar results are observed in Senegal (Jafari-Guemouri et al., 2005) , Sudan (Fadlelseed et al., 2017) . In Gabon, the predominant allele was FC27/MSP2 (Kassberger et al., 2002; Mayengue et al., 2004) . Allelic frequencies are very different from one family to another and the distribution of these alleles reveals the genetic variability present in the parasite population and might reflect the geographical variation of parasite genotype and the level of transmission.
Multi-clonal infection was detected respectively in 40 (35.1%), 24 (34.3%) and 32 (91.4%) of the peripheral, placental and cord samples. These results are the characteristic of the stable malaria transmission area (Mayengue et al., 2004) .
The MOI could be used in the evaluation of malaria interventions as it is an indicator of malaria infection in humans and may, to some extent, reflect transmission and immunity malaria (Smith et al., 1999) . In this cohort the MOI is lower than that reported (about 1.6 MOI) in the previous study in the same site (Ntoumi et al., 2016) and in other malaria endemic area (Beck et al., 2001; Walker-Abbey et al., 2005) . Furthermore, the low MOI could be explained by the use of impregnated mosquito nets and the degree of immunity. As a result, the low parasite density of this study, which results in low MOI, can be observed, but this did not affect the diversity of the parasites in circulation (Ibara-Okabande et al., 2012) .
The high prevalence of asymptomatic malaria in young pregnant women and those in their first and second pregnancies than those in their third or more pregnancies have reported (Smith et al., 1999) . With successive pregnancies, women acquire a gravidity-dependent antimalarial immunity, resulting in a decrease in both prevalence and severity of infection (Smith et al., 1999) . Studies have demonstrated a correlation between the MOI and parasite density as well as age of the study participants (Mayengue et al., 2004; Omer et al., 2011) . In our study, MOI was associated with neither maternal age nor gravidity, which is in line with other study (Kassberger et al., 2002; Walker-Abbey et al., 2005) . Age and the acquisition of pregnancy-related immunity do not appear to result in elimination of parasites or reduction of the number of different infecting strains. The SP doses have not reduced the MOI. This might result from the carriage of SP-resistant parasites in such women as suggested earlier (Moussiliou et al., 2013; KoukouikilaKoussounda et al., 2015; Ojurongbe et al., 2018) .
The cross-sectional nature of the study did not allow participants to be followed until delivery. The lack of current entomological data during the collection of samples and the lack of data on the use of mosquito nets by pregnant women do not allow us to deepen the analyses on the low multiplicity of infections.
Conclusions
In summary, this study showed that there is a high prevalence of sub-microscopic infection and a moderate genetic diversity of Plasmodium falciparum. Age, gravidity and doses of preventive treatment based on sulfadoxine-pyrimethamine do not interfere with the multiplicity of infections. These results contribute to the understanding of the dynamic of parasites in blood sample types during pregnancy and parasite population circulating in Congo.
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